Condition: Emphysema · COPD · Severe Emphysema · Sponsor: Pulmonx Corporation
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.
This description comes directly from the study's public registry record.
Joshua Percy · +1 650-810-1420 · jpercy@pulmonx.com
Always discuss trial participation with your own doctor first.
| Tosei General Hospital | Aichi, Japan | Recruiting |
| Gifu Prefectural Medical Center | Gifu, Japan | Recruiting |
| Kanagawa Cardio Chest Center | Kanagawa, Japan | Recruiting |
| Kanazawa University Hospital | Kanazawa, Japan | Recruiting |
| St Marianna University Hospital | Kawasaki, Japan | Recruiting |
| Matsusaka Civic Hospital | Mie, Japan | Recruiting |
| Nagasaki University Hospital | Nagasaki, Japan | Recruiting |
| Nagoya Medical Center | Nagoya, Japan | Recruiting |
| Okayama Medical Center | Okayama, Japan | Recruiting |
| Kinki Chuo Chest Medical Center | Osaka, Japan | Recruiting |
| Hokkaido University Hospital | Sapporo, Japan | Recruiting |
| Tohoku University Hospital | Sendai, Japan | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06332885